GENZYME CORP Gross Profit
GENZYME CORP reported Gross Profit of $815.82 million for the 3-month period ending 2010-12-31, per its 10-K filed 2011-03-01.
Discontinued › Income Statement
us-gaap:GrossProfit · last filed 2011-03-01
- GENZYME CORP gross profit for the quarter ending 2010-12-31 was $815.82M, a 27.33% increase year-over-year.
- GENZYME CORP gross profit for the quarter ending 2010-09-30 was $691.88M, a 7.69% increase year-over-year.
- GENZYME CORP gross profit for the quarter ending 2010-06-30 was $665.13M, a 18.30% decline year-over-year.
- GENZYME CORP gross profit for the quarter ending 2010-03-31 was $680.87M, a 13.74% decline year-over-year.
| Period end | Gross Profit 3 month | Gross Profit 6 month | Gross Profit 9 month | Gross Profit 12 month |
|---|---|---|---|---|
| 2010-12-31 | $815.82M 10-K · filed 2011-03-01 | $1.51B derived: sum of 2 quarters · filed 2011-03-01 | $2.17B derived: sum of 3 quarters · filed 2011-03-01 | $2.85B derived: sum of 4 quarters · filed 2011-03-01 |
| 2010-09-30 | $691.88M 10-K · filed 2011-03-01 | $1.36B derived: sum of 2 quarters · filed 2011-03-01 | $2.04B derived: sum of 3 quarters · filed 2011-03-01 | $2.68B derived: sum of 4 quarters · filed 2011-03-01 |
| 2010-06-30 | $665.13M 10-K · filed 2011-03-01 | $1.35B derived: sum of 2 quarters · filed 2011-03-01 | $1.99B derived: sum of 3 quarters · filed 2011-03-01 | $2.63B derived: sum of 4 quarters · filed 2011-03-01 |
| 2010-03-31 | $680.87M 10-K · filed 2011-03-01 | $1.32B derived: sum of 2 quarters · filed 2011-03-01 | $1.96B derived: sum of 3 quarters · filed 2011-03-01 | $2.78B derived: sum of 4 quarters · filed 2011-03-01 |
| 2009-12-31 | $640.72M 10-K · filed 2011-03-01 | $1.28B derived: sum of 2 quarters · filed 2011-03-01 | $2.10B derived: sum of 3 quarters · filed 2011-03-01 | $2.89B derived: sum of 4 quarters · filed 2011-03-01 |
| 2009-09-30 | $642.49M 10-K · filed 2011-03-01 | $1.46B derived: sum of 2 quarters · filed 2011-03-01 | $2.25B derived: sum of 3 quarters · filed 2011-03-01 | |
| 2009-06-30 | $814.09M 10-K · filed 2011-03-01 | $1.60B derived: sum of 2 quarters · filed 2011-03-01 | ||
| 2009-03-31 | $789.29M 10-K · filed 2011-03-01 |